Hitek Global Inc. Ordinary Share

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share. Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million. Xilio Therapeutics, Inc. (NASDAQ: XLO) gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers. Ontrak, Inc. (NASDAQ: OTRK) gained 55% to $0.9239. Binah Capital Group, Inc. (NASDAQ: BCG) gained 48% to $14.05 after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Allego N.V. (NASDAQ: ALLG) rose 32.8% to $1.7650. Akanda Corp. (NASDAQ: AKAN) gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Destiny Tech100 Inc. (NASDAQ: DXYZ) rose 26% to $22.15. REX American Resources Corporation (NYSE: REX) gained 23.2% to $54.15 following upbeat earnings. Nutriband Inc. (NASDAQ: NTRB) gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Summit Therapeutics Inc. (NASDAQ: ...

Related tickers: DXYZ, RH, MTTR, MARA, CZOO, XLO, OPK, BCG, MLKN, MSTR, KOD, PIK, PRST, NTRB, BRZE, CCL, NCNA, ALLG, EL, HUT, AKAN, CC, STRO, MRNO, DNA, GMDA, BDRX, REX, HKIT, MVLA, TNXP, AVTX, SEZL, ALT, UGRO, PMEC, GCTS, NKLA, ABTS, DTST, SOBR, CERO, SMMT, OTRK, RDDT, XXII, KTRA.

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast. The company said it sees full-year 2024 demand growth of 12% to 14% and revenue growth of 8% to 10% on a year-over-year basis, according to data from Benzinga Pro. RH shares jumped 9.4% to $324.99 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) rose 256.6% to $16.94 in pre-market trading after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. Binah Capital Group, Inc. (NASDAQ: BCG) gained 149% to $23.65 in pre-market trading after dipping more than 20% on Wednesday. Kidpik Corp. (NASDAQ: PIK) gained 49.5% to $4.89 in pre-market trading. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares rose 36.3% to $0.1220 in pre-market ...

Related tickers: LGVN, CZOO, CC, MLKN, GCTS, PIK, XXII, MVLA, RH, ABTS, AKBA, BCG, GCT, NCNA, GMDA, HKIT, AVTX, UGRO, SOBR, KTRA.